Qi Fu,Zijian Zhao,Donghui Yin
Qi Fu
This review delineates the pivotal role of nursing and rehabilitation in perioperative management and chemotherapy support for lung cancer patients, with a focus on complication prevention, nutritional support, pulmonary rehabilitation (PR)...
In Need of Rescue: Modernizing and Redefining Treatment Intent in Oncology [0.03%]
亟待救援：肿瘤学治疗目的的现代化和重新定义
Howard Yu,Roland Yeghiaian-Alvandi
Howard Yu
Pan-Cancer Analysis and Functional Characterization Identify SLC15A4 as a Novel Prognostic Biomarker and Therapeutic Target [0.03%]
泛癌分析及功能表征鉴定出SLC15A4是一个新型预后生物标志物和治疗靶点
Xiaodan Lyu,Ziming Lin,Ya Lin et al.
Xiaodan Lyu et al.
SLC15A4 is a transporter protein known to be involved in immune regulation, but its role in cancer is not well understood. This study aimed to thoroughly investigate SLC15A4 across different cancers, focusing on its expression levels, link ...
Stereotactic Ablative Radiotherapy for Central Lung Tumors: A Preliminary Study Assessing the Feasibility of Continuous Positive Airway Pressure [0.03%]
中心型肺癌立体定向消融放射治疗中持续气道正压通气可行性初步研究
Gareth I Le Grice,Suzanne Lydiard,Uta Machold et al.
Gareth I Le Grice et al.
Introduction: Continuous positive airway pressure (CPAP) has been demonstrated to provide favorable physiological changes for lung stereotactic ablative radiotherapy (SABR) delivery. This study investigates its specific u...
Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center Cohort [0.03%]
表皮生长因子受体阳性非小细胞肺癌使用第一代或第二代表皮生长因子受体酪氨酸激酶抑制剂治疗的长期幸存者相关因素：加拿大多中心队列研究
Heather Halperin,Amanda J W Gibson,Ali Hussein et al.
Heather Halperin et al.
Background: In East-Asian predominant populations, multiple reports identify East-Asian ancestry as prognostic of improved outcome in EGFRmut+ non-small cell lung cancer (NSCLC) populations when treated with first/second ...
Epstein-Barr Virus-positive NK/T-cell Malignancies in Poland: Distinctive Features, Therapeutic Strategies, and Survival Insights-The Real-world Retrospective Report of the Polish Lymphoma Research Group [0.03%]
波兰阳性EB病毒自然杀伤T细胞恶性肿瘤的特征、治疗策略及生存率分析：波兰淋巴瘤研究小组的真实世界回顾性报告
Kateryna Filonenko,Ewa Paszkiewicz-Kozik,Joanna Drozd-Sokolowska et al.
Kateryna Filonenko et al.
Aim: Extranodal NK/T-cell lymphoma (ENKTCL) and aggressive NK-cell leukemia (ANKL) are rare aggressive hematologic malignancies. Genetic differences and varying Epstein-Barr virus (EBV) strains suggest potential dispariti...
Extranodal (Nasal Variant) NK/T -Cell Lymphoma of Head and Neck: Our Experience From a Tertiary Care Centre [0.03%]
头颈部结外型(NASAL VARIANT)NK/T细胞淋巴瘤：三级医疗中心的诊疗经验
Manu C Balakrishnan,Suvamoy Chakraborty,Zareen Lynrah et al.
Manu C Balakrishnan et al.
Background: Extranodal nasal variant NK/T-cell lymphomas (ENNK) are rare, particularly in the Indian population, with limited published cohorts. This study evaluates the clinical presentation and immunohistochemical (IHC)...
Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology [0.03%]
澳大利亚成人IDH突变型胶质瘤诊疗专家共识(神经肿瘤合作试验组发布)
Mark B Pinkham,Hao-Wen Sim,Rosalind L Jeffree et al.
Mark B Pinkham et al.
Isocitrate dehydrogenase (IDH)-mutant low-grade and high-grade gliomas are primary brain cancers with slower growth rates and longer survival than IDH-wildtype counterparts. However, these tumors are fatal and because of the younger age of ...
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter Study [0.03%]
澳大利亚真实世界多中心移植不适合的新诊断骨髓瘤患者每周使用硼替佐米、来那度胺和地塞米松方案的有效性和耐受性研究
Samantha Kurniawan,Angela Hwang,Nicole Wong Doo et al.
Samantha Kurniawan et al.
Background: Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to upfront anti-CD38 therapy within the Asia-Pacific. However...